CTOs on the Move


 
Foria is an innovative health & sexual wellness company, rooted in the proven wisdom of plants and powered by compassion. Our all natural Cannabis & Hemp formulas have been changing lives since 2014. As the first brand to create comprehensive product lines for intimacy, relief, and optimal wellbeing for women and people with vulvas, it is our joy and mission to offer effective products for important and under-served life experiences. With an unwavering commitment to clean ingredients, organic & regenerative farming, sex education, and responsible packaging, we maintain the highest standards of purity and transparency — for your health, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

My Brother's Keeper

My Brother's Keeper is a Ridgeland, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vitamin Discount Center

Vitamin Discount Center Incorporated is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alliant Healthcare Products

Alliant Healthcare Products is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Momentum Healthware

Momentum Healthware Inc. is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.